tiprankstipranks
China Resources Pharma Announces Major Acquisition
Company Announcements

China Resources Pharma Announces Major Acquisition

China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.

Invest with Confidence:

China Resources Pharmaceutical Group Ltd. has announced a major acquisition, with its subsidiary CR Boya Bio-pharmaceutical conditionally agreeing to purchase 100% of Green Cross HK for about RMB 1.82 billion, turning it into a non-wholly-owned subsidiary. Alongside the acquisition, a Strategic Cooperation Framework Agreement was signed to promote future business integration and pharmaceutical collaborations, although specific future projects remain subject to further agreements and market conditions.

For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App